Equine Metabolic Syndrome and Insulin Dysregulation.

Equine metabolic syndrome (EMS) is a condition in horses characterized by problems with insulin regulation that can lead to painful hoof disease called laminitis. Diagnosing and managing EMS focuses on identifying insulin issues and applying dietary, exercise, and sometimes medication strategies to reduce risks.

Introduction to Equine Metabolic Syndrome (EMS)

• EMS is a syndrome in horses marked by a group of metabolic and clinical traits.
• It primarily involves insulin dysregulation (ID), which means the horse has abnormal insulin responses.
• The consequence of these issues often leads to hyperinsulinemia-associated laminitis (HAL), a painful, potentially debilitating hoof disease.

Insulin Dysregulation and Its Role

• ID is the central feature of EMS and is characterized by inappropriate insulin secretion or response.
• This dysregulation is a major risk factor for the development of laminitis related to elevated insulin.
• Understanding and identifying ID is critical for predicting and preventing laminitis episodes in affected horses.

Diagnostic Approaches

• Several diagnostic tests exist to identify the presence and type of insulin dysregulation in horses and ponies.
• Testing typically involves measuring blood insulin and glucose levels before and after challenge tests.
• These diagnostic tests help in assessing the severity and form of ID, guiding treatment decisions.

Treatment Strategies for EMS and ID

• Management focuses primarily on modifying diet to reduce carbohydrate intake, which decreases insulin spikes.
• Exercise programs are implemented to improve insulin sensitivity and promote weight loss.
• In severe cases, pharmacologic treatment is used to directly target insulin regulation or support metabolic health.
• Ongoing monitoring is necessary to adjust treatment plans and prevent laminitis development.